Pharma
Stay updated with the latest happenings in the pharmaceutical industry. Get insights into drug development, innovations, regulatory updates, and emerging trends. Discover the advancements shaping the future of healthcare. Explore the world of pharma with our comprehensive coverage at Pharmtales.com.
Novartis Announces Strong Revenue Growth, Share Buyback, and Sandoz Separation
Source – Novartis Novartis, a pharmaceutical company, has announced a new $15 billion stock repurchase plan after completing a previous ...
FDA Acceptance of sNDA for Fifth BRUKINSA Indication Announced by BeiGene
Source – Beigene BeiGene, a prominent global biotechnology company, made a groundbreaking announcement today. The US Food and Drug Administration ...
Advanced RCC Tumor Sequencing Identifies Host Signatures Associated with Immunotherapy Response
In a single-center study presented at the 2023 Kidney Cancer Research Summit, researchers found that patients with metastatic renal cell ...
FDA Issues ODD for Gallium Maltolate for Pediatric GBM
Imaging Biometrics announced that gallium maltolate (GaM) has received orphan drug designation (ODD) from the FDA for the treatment of ...
Treatment for Advanced HNSCC With ASP-1929 and Anti-EGFR Therapy Is Effective
Source – Rakuten Medical Promising early results have been observed with ASP-1929, in combination with anti-PD-1 therapy, for patients with ...
A UK initiative will test an EEG gadget for the identification of Alzheimer’s
Source – Cumulus Neuroscience Digital health company Cumulus Neuroscience has joined forces with two UK universities to advance the development ...
First Wave BioPharma’s Pancreatic Enzyme Replacement Therapy Faces Hurdles, Stock Plummets
Source – First Wave BioPharma First Wave BioPharma, formerly known as AzurRx BioPharma, has faced ongoing challenges in bringing a ...
GSK’s Star-Studded Reunion Amplifies Meningitis Awareness Campaign
GSK has brought together Soleil Moon Frye and Melissa Joan Hart, stars of “Sabrina the Teenage Witch,” for its latest ...
Investor Lawsuit Targets Mallinckrodt for Alleged False Statements Regarding Financial Health
After Mallinckrodt Pharmaceuticals’ emergence from Chapter 11 reorganization and a $1.7 billion settlement for opioid claims, the company now faces ...
Johnson & Johnson Files Lawsuit Against Four Doctors Over Alleged Biased Opinions in Talc Defense Cases
As Johnson & Johnson (J&J) seeks ways to address its talc-related legal challenges, the company has resorted to a new ...
Lilly’s Acquisition of Versanis Aims to Enhance Patient Outcomes in Cardiometabolic Diseases
Source – Eli Lilly Eli Lilly and Versanis Bio have reached a definitive agreement for Lilly to acquire Versanis, a ...
Enhertu Receives Approval in China as Groundbreaking HER2-Directed Therapy for HER2-Low Metastatic Breast Cancer Patients
Source – AstraZenecaĀ Enhertu (trastuzumab deruxtecan), a targeted antibody drug conjugate developed by AstraZeneca and Daiichi Sankyo, has received approval ...
FDA states that LN-145 in NSCLC is likely to receive accelerated approval
Source – Iovance Biotherapeutics The Phase II IOV-LUN-202 trial of LN-145 in patients with post-anti-PD-1 non-small cell lung cancer (NSCLC) ...
The Arrival of OTC birth control in the US
Source – FDA The US has approved the first-ever over-the-counter (OTC) contraceptive pill, providing women with a new option for ...
Roche’s Potential $7billion Acquisition: Exploring the Purchase of Roivant’s Promising Drug
According to media reports, Roche is said to be in the final stages of negotiations with Roivant for a potential ...
Funding for digital health will be at its lowest level since 2019
According to a report from Rock Health, the funding landscape in digital health is experiencing a downturn, characterized by fewer ...
In its COVID-19 vaccination lawsuits against Pfizer and BioNTech, CureVac makes further claims under the patent statute
Source – CureVac CureVac is intensifying its patent battle over COVID-19 vaccines by asserting additional claims against Pfizer and BioNTech ...
Haleon plans significant layoffs in the UK and elsewhere to save costs: report
Almost exactly one year after GSK’s consumer healthcare business spun off as Haleon, the company is reportedly implementing widespread layoffs ...
To increase treatment and adherence rates for children with HIV in low- and middle-income countries, Gilead collaborates with CHAI and Penta
Source – Gilead Sciences Gilead Sciences is pleased to announce two collaborative initiatives. The first initiative aims to expedite the ...
Research-Driven Design to Enhance the Patient Experience
Imagine you are a patient needing medication for a chronic condition. You open the package and find a long, complicated ...
Multiple Myeloma: What You Need to Know About the Latest Advances
Multiple myeloma is a type of blood cancer that affects plasma cells, which are responsible for producing antibodies that help ...
How BCMA-targeted therapies are changing the game for multiple myeloma
Imagine a world where you could treat cancer with a simple injection or infusion, without the need for surgery, chemotherapy, ...
FDA-Approved Medications for Multiple Myeloma: What You Need to Know
Let’s find out FDA-approved medications for multiple myeloma. Multiple myeloma is a type of blood cancer that affects plasma cells, ...
The first respiratory syncytial virus (RSV) vaccine for elderly people, GSK’s Arexvy, received approval from the Medicines and Healthcare Products Regulatory Agency
Source – GSK GSK has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...
Zanubrutinib Plus Obinutuzumab for R/R Follicular Lymphoma Receives FDA Acceptance of sNDA
Source – BeiGene BeiGene has announced that the FDA has accepted a supplemental new drug application (sNDA) for the combination ...
Merck awards pandemic early warning system with a prize of ā¬500,000
The annual Future Insight competition held by Germany’s Merck KGaA has awarded a ā¬500,000 prize to Khalid Salaita, a professor ...
NHS may increase the cost of new antibiotic subscriptions
Proposals are underway to double the yearly subscription payments made by NHS England to developers of innovative antibiotics from Ā£10 ...
Illumina was penalized ā¬432 million for disregarding Grail merger opposition
The European Commission has imposed a significant penalty on Illumina, a leading DNA sequencing company, for finalizing its acquisition of ...
Merck increases its pressure on the IRA by requesting a ruling without a trial in its conflict with the US government
Merck is intensifying its fight against the drug price negotiation provisions in the Inflation Reduction Act (IRA) by requesting a ...
Despite a lack of essential cancer medications, the FDA approves additional chemotherapy imports from China’s Qilu Pharmaceutical
The ongoing shortage of crucial chemotherapy drugs in the United States has led the FDA to import a supply from ...
